Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|9|6|447-467

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.9, Iss.6, 2008-12, pp. : 447-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Dirks Nathanael L.   Meibohm Bernd  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Keizer Ron J.   Huitema Alwin D.R.   Schellens Jan H.M.   Beijnen Jos H.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 493-507

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies

By Yan Li   Davis Hugh M  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 961-964

Future Medicine

Access to resources Recommend Favorite

Transgenic Mouse Strains as Platforms for the Successful Discovery and Development of Human Therapeutic Monoclonal Antibodies

By  

Current Drug Discovery Technologies, Vol. 11, Iss. 1, 2014-03 ,pp. : 74-84

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Monoclonal Antibodies in Myocardial Reperfusion Injury

By Nigam A.   Kopecky S.L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 367-376

Adis International

Access to resources Recommend Favorite